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Abstract 
Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) caused a severe 
outbreak in several regions of the world in 2003. The SARS-CoV genome is predicted to 
contain 14 functional open reading frames (ORFs). The first ORF (1a and 1b) encodes a 
large polyprotein that is cleaved into nonstructural proteins (nsp). The other ORFs encode 
for four structural proteins (spike, membrane, nucleocapsid and envelope) as well as eight 
SARS-CoV-specific accessory proteins (3a, 3b, 6, 7a, 7b, 8a, 8b and 9b). In this report we 
have cloned the predicted nsp8 gene and the ORF6 gene of the SARS-CoV and studied 
their abilities to interact with each other. We expressed the two proteins as fusion 
proteins in the yeast two-hybrid system to demonstrate protein–protein interactions and 
tested the same using a yeast genetic cross. Further the strength of the interaction was 
measured by challenging growth of the positive interaction clones on increasing gradients 
of 2-amino trizole. The interaction was then verified by expressing both proteins 
separately in-vitro in a coupled-transcription translation system and by 
coimmunoprecipitation in mammalian cells. Finally, colocalization experiments were 
performed in SARS-CoV infected Vero E6 mammalian cells to confirm the nsp8– ORF6 
interaction. To the best of our knowledge, this is the first report of the interaction between 
a SARS-CoV accessory protein and nsp8 and our findings suggest that ORF6 protein may 
play a role in virus replication. 
Introduction 
Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease. The 
etiologic agent of SARS has been identified as a novel coronavirus, namely SARS-
associated coronavirus (SARS-CoV) (Ksiazek et al., 2003; Marra et al., 2003; Peiris et 
al., 2003; Rota et al., 2003). As of June 30th, 2003, 8447 probable SARS cases 
including 811 deaths were reported by the World Health Organization (WHO) from 32 
countries or regions worldwide. The significant morbidity and mortality, and the potential 
for re-emergence, makes SARS-CoV a continued worldwide public health threat. 
Like other known coronaviruses, SARS-CoV is an enveloped, plus-strand RNA virus 
that features the largest RNA genomes currently known. The SARS viral genome 
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comprises approximately 30,000 nucleotides, which are organized into 14 functional open 
reading frames (ORFs) (Rota et al., 2003; Thiel et al., 2003). Analysis of the nucleotide 
sequence of this novel coronavirus revealed a similar pattern of gene organization 
typical of coronaviruses (Marra et al., 2003; Rota et al., 2003). Two large, 5′-terminal 
overlapping ORFs, 1a and 1b of the replicase gene encode two polyproteins, pp1a and 
pp1ab (Fig. 1) (Rota et al., 2003; Thiel et al., 2003). Like other coronaviruses, the nascent 
SARS-CoV replicase polyproteins are processed by virus-encoded proteinases, and in this 
case, two proteinases have been identified: a 3C-like proteinase (3CLpro) and a 
papain-like proteinase (PLP) (Denison et al., 1992; Snijder et al., 2003; Ziebuhr, 2004). 
Fig. 1. Cloning of the putative nsp8 and ORF6 genes from the SARS CoV genome. The full-length nsp8 (198 amino 
acids) and ORF6 (66 amino acids) genes of the SARS coronavirus (Tor2 isolate) were PCR-amplified from a genomic 
construct of clone NC_004718 and cloned into the pCR-XL-TOPO vector (Invitrogen) as described in Table 1. The 
scale on top shows genomic region. 
The processed end products of pp1a are designated nonstructural proteins (nsp) 1 to nsp11 
and those of pp1ab are designated nsp1 to nsp16. Cleavage by the viral main protease, 
3CLpro results in generating the nsp8 protein which is currently of undesignated
function. The nsp8 protein has been shown to associate with several other nsps and to 
colocalize with these nsps in cytoplasmic complexes that are important for viral RNA 
synthesis (Prentice et al., 2004a, 2004b; Sutton et al., 2004; Zhai et al., 2005). The 
+RNA coronavirus usually encode a non-structural protein (nsp12 for SARS-CoV) that 
includes an RdRp domain, conserved in all RNA viruses. The SARS-CoV uniquely 
encodes a second RdRp residing in nsp8, responsible for initiation of the synthesis of 
complementary oligonucleotides smaller than 6 residues long, at relatively low fidelity. 
These nsp8 RdRp produced primers are postulated to be utilized by the primer-
dependent nsp12 RdRp for replication (Imbert et al., 2006). 
The remaining 12 ORFs encode the four structural proteins, spike (S), membrane (M), 
nucleocapsid (N) and envelope (E), and eight accessory proteins (3a, 3b, 6, 7a, 7b, 8a, 8b 
and 9b). These accessory proteins are postulated to be non-essential in tissue culture 
but may provide a selective advantage in the infected host. The ORF3a protein has 
been studied to some details (Tan et al., 2006) and has been shown to be expressed in 
infected cells (Tan et al., 2004c; Yu et al., 2004; Zeng et al., 2004). ORF3a protein has 
been shown to bind the spike protein (Zeng et al., 2004; Tan et al., 2004c) and recent 
work demonstrated that it is a novel structural protein (Ito et al., 2005). The ORF7a 
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protein was also detected in infected cells and has been found to localize in the ER-
Golgi intermediate compartments where coronaviruses are known to assemble 
(Fielding et al., 2004; Nelson et al., 2005). In addition, ORF3a, ORF3b  and  ORF7a 
proteins  have  been  shown  to  induce apoptosis (Tan et al., 2004a; Law et al., 2005; Yuan 
et al., 2005). 
Two recent papers on the ORF6 accessory protein also demonstrated its expression 
during infection and have showed that it may be important for viral pathogenesis (Geng 
et al., 2005; Pewe et al., 2005). Most recently the ORF6 protein has been shown to 
accelerate replication of a related mouse virus, a property that may contribute towards 
its increased in vivo virulence (Tangudu et al., 2007). 
In this study, the nsp8 and ORF6 proteins were tested for interaction in a yeast cellular 
environment using the yeast two- hybrid system. These interactions were further verified 
by in-vitro coimmunoprecipitation experiments using proteins expressed by a 
coupled-transcription/translation system or in mammalian cells by lipid-mediated 
transfection of DNA. Finally, the nsp8–ORF6 interaction was confirmed by 
colocalization of the two proteins in SARS-CoV infected mammalian cells (Vero E6). This 
unique SARS-CoV accessory protein 6 interacting with a non-structural protein, nsp8, 
suggests that ORF6 may have a role in SARS virus replication. 
Results and discussion 
The nsp8 protein of the SARS coronavirus was cloned from the Tor2 Singapore isolate 
and expressed using the yeast two-hybrid vectors resulting in an N-terminal in-frame 
fusion protein with the GAL4 activation domain (AD). Similarly the ORF6 protein was 
PCR cloned and expressed in yeast two-hybrid vectors resulting in an N-terminal in-
frame fusion protein with the GAL4 DNA binding domain (BD). In order to check for 
correct reading-frame constructs, the final plasmids were sequenced and checked for in-
vitro protein expression. Saccharomyces cerevisiae AH109 cells were transformed with 
single plasmids, or co-transformed with the GAL4 BD- and AD-vectors containing 
SARS Co-V ORF6 and/or nsp8, respectively. The AH109 host strain containing pAS2-
N and pACT2-N were used as positive controls (Surjit et al., 2004). 
AH109  contains  integrated  copies  of  both  HIS3  and  lacZ reporter genes under the 
control of GAL4 binding sites. The results of the two-hybrid assay are shown in Fig. 2A. 
Single transformants used in this assay were yeast (AH109) cells containing BD-
ORF6, and host cells containing AD-nsp8, also yeast cells containing only the BD- and 
only the AD-vectors, were also used as negative controls. All these transformants and co-
transformants grew well on the unrestricted YPD plate (non- selective media). Also, the 
untransformed host cells were plated as a negative control. Single transformants containing 
the BD-by itself or as a fusion with the ORF6 protein, showed growth on the synthetic 
dextrose Trp− plate (SDTrp−).
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Fig. 2. Yeast two-hybrid results showing that nsp8 and ORF6 proteins interact with each other. (A) AD-nsp8 fusion 
protein and BD-ORF6 fusion protein tested as single and co-transformants on various synthetic growth media lacking 
specific amino-acids. YPD media shows uninhibited growth of all transformants and host strain. SDTrp− and SD-
Leu− selective media have Tryptophan and Leucine missing, respectively. SD Trp−Leu−His− media are triple 
dropout plates lacking Tryptophan, Leucine and Histidine. Growth on the SD Trp−Leu−His− plate and blue color (shown 
here in shades of grey) on the β-gal filter assay represents a positive interaction. BD-N:AD-N combination was used as 
a positive control in these yeast two-hybrid experiments (Surjit et al., 2004). (B) Liquid β-galactosidase assay results 
of the nsp8–ORF6 protein–protein interactions. Single transformants and co-transformants were analyzed in a liquid β-
galactosidase assay and compared with each other. Values given are in arbitrary units. The numbers above each bar 
represent the mean from five independent transformants. Y187 corresponds to the untransformed host strain. 
Transformants with more than one plasmid are separated by a slash. Positive controls used in this assay are denoted by 
BD-SNF1/AD-SNF4 (Harper et al., 1993). (C) Measurement of strength of the nsp8–ORF6 interactions on an increasing 
3-AT gradient. Activation of the HIS3 reporter was determined for the host AH109 strain, single transformants (BD, 
AD, BD-ORF6 and AD-nsp8), and co-transformants (BD-ORF6/AD-nsp8 and BD-N/AD-N). Hundred-fold serial 
dilutions of all of the above-mentioned log-phase cultures were plated on YPD (left) followed by SD-His-plus 50 mM 
3-AT in increasing concentrations (0 mM to5 mM 3-AT). 
 
Correspondingly, single transformants containing the AD- by itself or as a fusion with 
nsp8 showed growth on the synthetic dextrose Leu− plate (SDLeu−). The co-
transformants were similarly plated on YPD and synthetic dextrose medium lacking Trp 
or Leu or Trp, Leu and upon positive growth on these was subsequently plated on His− 
medium (SD Trp−Leu−His−) to test for His prototrophy. Growth of the co-
transformants, containing the BD-ORF6 and AD-nsp8 constructs, in both SDTrp− and 
SDLeu− plates simply showed that both plasmids were present in the transformed cells. 
Growth of these clones on the SD Trp−Leu−His− media showed that the transcription of 
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the HIS3 gene was turned on by the reconstitution of the GAL4 transactivator due to 
a specific ORF6–nsp8 interaction. Colonies were transferred on to nitrocellulose filters 
and a β-galactosidase filter assay was per- formed as described in methods. The co-
transformants contain- ing both the BD-ORF6 and AD-nsp8 constructs along with all 
positive and negative controls were used in this assay. Results obtained from  the  β-
galactosidase  filter  assay  were  in agreement with the results obtained from the 
SDHis− growth experiments. 
 
The liquid β-galactosidase assay was conducted and the activity determined using the 
substrate chlorophenol red-β-D- galactopyranoside (CPRG) as described in methods. 
The host strain alone, along with single transformants containing either AD-nsp8 or BD-
ORF6 and co-transformants containing AD-/ BD- without a fusion protein was tested. 
Negative controls (host untransformed cells) showed almost no liquid β-galactosidase 
activity. BD-SNF1/AD-SNF4 was the positive control whereas the clones containing BD-
ORF6/AD-nsp8 were the test samples in this experiment (Fig. 2B). Relative enzymatic 
activity was determined in five independent transformants from each group. Our results 
from this assay indicate a moderate strength protein–protein interaction between the 
AD-nsp8 and BD- ORF6 proteins. This observation was further confirmed by the use of a 
3-AT gradient on which the His+ phenotype was tested (Fig. 2C). 3-AT is known to be a 
competitive inhibitor of HIS3 protein, thus enhancing the stringency of selection, it 
reduces the background signal by inhibiting the product of the HIS3 reporter. This 
result clearly showed that the interaction of nsp8 with ORF6 was not as strong as the N–N 
dimerization positive control interaction. On plates with increasing concentrations of 3-
AT, the growth ability of the His+ colonies diminished and was almost undetectable at 5 
mM 3-AT concentrations. 
 
To further confirm these interactions we performed a coimmunoprecipitation assay 
using proteins expressed by a cell-free coupled transcription–translation system. The 
rabbit reticulocyte lysates expressing His6-nsp8 and myc-ORF6 proteins separately 
were tested for expression (Fig. 3A). For detection of the expressed proteins, the lysates 
were immuno-precipitated using the respective antibodies i.e. anti-His antibody was 
used for detection of the nsp8 protein and anti-myc antibody was used for the detection 
of the ORF6 protein. When the two cell lysates were mixed in equal proportions, one of 
the two antibodies was added and subsequently pulled out using Protein A Sepharose 
beads, we observed the interacting protein to be present in the gel as well. This 
procedure was repeated conversely to show the other corresponding antibody pull out 
the interacting protein partner as well (Fig. 3B). When anti-His antibody was used to pull 
out the nsp8 protein from the mixture of proteins, it also pulled out the ORF6 protein. 
Similarly, when anti-myc antibody was used to pull out the ORF6 protein, the nsp8 
protein was also observed to be pulled out as an interaction partner of ORF6. In a control 
experiment we observed no ORF6 protein binding directly to the anti-His antibody 
Sepharose-A complex and similarly observed no binding of the nsp8 protein to the anti-
myc antibody Separose-A complex (Fig. 3C). These results clearly showed that the two 
proteins nsp8 and ORF6 interacted with each other. 
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Fig. 3. Confirmation of the nsp8–ORF6 interaction using an in-vitro cell-free coupled transcription/translation 
coimmunoprecipitation assay. (A) The His6-tagged nsp8 and myc-tagged ORF6 proteins were produced by coupled 
transcription–translation in the presence of 35S-Met and detected using their corresponding antibodies (Anti-His and 
anti-myc, respectively). Both nsp8 and ORF6 proteins were visible and corresponded to their correct molecular sizes 
on 12% and 20% SDS-PAGE, respectively. (B) The 35S-Met-His-nsp8 and 35S-Met-myc-ORF6 proteins were detected 
by autoradiography. The nsp8–ORF6 complex was detected by both anti-His and anti-myc antibodies on 16% SDS-
PAGE. When nsp8 was probed for using anti-His antibody, the ORF6 protein was visible and when ORF6 protein was 
probed using myc antibody, the nsp8 protein was visible. (C) In a control reaction, the 35S-Met-His6-nsp8 and 
35S-
Met-myc-ORF6 proteins showed no cross-reactivity with the other antibody used in the pull-down experiments. Also 
this control experiment shows that the proteins do not non-specifically bind to the beads used in the results shown in 
panel B. Lane 1 shows the nsp8 protein immunoprecipitated by anti-His, lane 2 does not show nsp8 protein band when 
immunoprecipitated by anti-myc. Similarly, lane 3 shows myc-tagged ORF6 protein immunoprecipitated by anti-myc 
and lane 4 does not show ORF6 protein where it was immunoprecipitated using anti-His. 
 
 
Fig. 4. (A) Cell lysates were obtained from Vero E6 cells expressing ORF6 and myc-nsp8 or ORF6 and myc-GST 
(negative control) and subjected to Western blot analysis with either anti-ORF6 polyclonal (upper panel, lanes 1 and 
2) or anti-myc monoclonal antibodies (lower panel, lanes 1 and 2). Equal amounts of lysates were subjected to 
immunoprecipitation using anti-myc polyclonal antibodies and protein A beads. The immuno-complexes were 
subjected to Western blot with either anti-ORF6 polyclonal (upper panel, lanes 3 and 4) or anti-myc monoclonal 
antibodies (lower panel, lanes 3 and 4). (B) Equal amounts of total cellular protein from Vero E6 cells either uninfected 
(lane 1) or infected with wildtype Dryvax (lane 2), a recombinant vaccinia virus expressing the SARS-CoV S 
protein (lane 3), or the recombinant vaccinia virus expressing the ORF6 protein used in this study (lane 4) were 
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subjected to Western blot and probed with anti-ORF6 rabbit polyclonal antibody. This demonstrates that the ∼ 37 kDa 
band seen in lanes 1 and 2 of panel A is a cross-reacting protein that is probably a vaccinia virus protein or an up-
regulated cellular protein which is detected by the rabbit anti-ORF6 antibody used in this study. 
 
In order to verify the interaction between nsp8 and ORF6 in mammalian cells, co-
immunoprecipitation experiments were performed using lysates obtained from Vero 
E6 cells expressing transiently  transfected  myc-tagged  nsp8  and untagged ORF6 
proteins carried by a replicative recombinant vaccinia virus. Myc-polyclonal antibody 
conjugated to protein A Sepharose beads was used to pull-down myc-nsp8 or myc- GST 
(negative control), and any ORF6 protein that co- immunoprecipitated was detected 
using a rabbit polyclonal antibody raised against a peptide of ORF6 (Abgent). This 
antibody specifically detected the ORF6 protein (∼ 7 kDa) in cells that were infected with 
ORF6 recombinant vaccinia virus (Fig. 4, lanes 1 and 2). As shown in Fig. 4, ORF6 was 
co-immuno- precipitated by myc-nsp8 (lane 3) but not by myc-GST (lane 4), showing that 
the ORF6 and nsp8 proteins can interact in Vero E6 cells. 
 
In order to confirm that the interaction between nsp8 and ORF6 occurs during SARS-
CoV infection, co-immunoprecipi- tation experiments were performed with lysates 
obtained from SARS-CoV infected cells. Infection of Vero E6 cells with an isolate of 
SARS-CoV (strain HKU 39849) was carried out in a physical containment level 4 (PC4) 
laboratory as previously described (Kaye et al., 2006). The cells were harvested at 0 or 
24 h post-infection (h.p.i.) and the lysates were subjected to Western blot analysis to 
determine the expression of nsp8 and ORF6 proteins (Fig. 5). Two specific proteins in the 
cells at 24 h. p.i. were detected with purified supernatant from hybridomas producing 
monoclonal antibodies against the nsp8 protein (see Materials and methods) and these 
were not found in the cells harvested at 0 h.p.i. (upper panel, lanes 1 and 2). The protein 
that migrated at ∼ 24 kDa matched the predicted molecular mass of nsp8 while the slower 
migrating protein (∼ 65 kDa) may be an aggregated form of nsp8. 
 
 
Fig. 5. Lysates were obtained from SARS-CoV infected Vero E6 cells harvested 
at 0 or 24 h post infection (h.p.i.) and Western blot analyses were performed to determine the expression of SARS-CoV 
proteins using mouse anti-nsp8 mono- clonal antibody (upper panel, lanes 1 and 2) and rabbit anti-ORF6 polyclonal 
antibody (lower panel, lanes 1 and 2). Cell lysates obtained at 24 h.p.i. were then subjected to immunoprecipitation using 
anti-Flag (irrelevant antibody as nega- tive control) or anti-ORF6 rabbit polyclonal antibodies and protein A beads. The 
immuno-complexes were subjected to Western blot analysis with mouse anti- 
nsp8 monoclonal antibody (upper panel, lanes 3 and 4). 
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As expected, the ORF6 protein was also detected at 24 h.p.i. and not at 0 h.p.i. (lower 
panel, lanes 1 and 2). Cell lysates obtained at 24 h.p.i. were then subjected to 
immunoprecipitation with either an irrelevant antibody (rabbit anti-Flag  polyclonal  
antibody,  lane  3)  or  rabbit  anti-ORF6 polyclonal antibody  (lane 4) and protein-A  
agarose beads. Western blot analyses showed that nsp8 protein (∼ 24 kDa) was co-
immunoprecipitated when anti-ORF6 antibody was used but not when an irrelevant 
antibody was used, indicating that the nsp8 interacts specifically with ORF6 in SARS-
CoV infected cells (upper panel, lanes 3 and 4). 
 
Indirect immunofluorescence analysis of ORF6 expression in SARS-CoV-infected cells 
(Fig. 6, middle panel) showed that, consistent with previous publications (Geng et al., 
2005; Pewe et al., 2005), ORF6 was found in the cytoplasm. Most of the ORF6 protein 
seen in infected cells were observed in a punctate staining pattern consistent with a 
vesicle-associated intracellular distribution. Using the rabbit polyclonal antibody against 
ORF6 (Abgent) and purified supernatant from hy- bridomas producing monoclonal 
antibodies against the nsp8 protein (see Materials and methods), cells infected with 
an isolate of SARS-CoV (strain HKU39849) were examined by indirect 
immunofluorescence to determine if the two proteins colocalized, as their interaction 
would suggest. The extent of colocalization seen between the two proteins was 
significant, both localizing to the same set of punctate structures (Fig. 6, middle panel, 
D). The punctate distribution of nsp8 has been previously described (Prentice et al., 
2004a) and the colocalization of ORF6 protein with nsp8 suggests that ORF6 could 
be associated with the SARS-CoV replicase complex, localized to a subset of the vesicular 
trafficking complex in mammalian cells. These ORF6-containing vesi- cular structures 
did not colocalize with AP-1 and LAMP-2 (data not shown), which are present in 
early and late endosomes respectively. However, the ORF6 protein does colocalize with 
LAMP-1 (Fig. 7), which is a lysosomal marker. LAMP-1 has been used as a marker for 
characteristic double-membrane vesicles seen in infections by other viruses (Jackson et 
al., 2005) and it has been shown that at least one other coronavirus induces these 
double-membrane vesicles, presumably as a site for the assembly of virus replication 
complexes (Prentice et al., 2004b). Given this, the ORF6 protein might localize to these 
vesicles which have been suggested to be derived from the cellular autophagosomal 
machinery, but further study will be required. A recent struc- tural study of the nsp8 
protein has suggested a role for the nsp8–nsp7 hexadecamer in binding dsRNA 
intermediates in the viral replication cycle (Zhai et al., 2005), further lending impetus 
to such a study. This is the first report describing the interaction between the ORF6 
accessory protein and the nsp8 protein. We demonstrated the strength and specificity 
of this interaction by three independent methods, i.e. by yeast-2-hybrid, co- 
immunoprecipitation using in-vitro translated proteins in a cell-free system and co-
immunoprecipitation using lysates from Vero E6 cells. Interestingly, two previous 
publications on ORF6 have shed some light on its possible function in viral 
pathogenesis. Geng and co-workers detected ORF6 protein in lung and intestine of 
SARS patients and showed that it could stimulate cellular  DNA synthesis when over- 
expressed (Geng et al., 2005). Pewe et al. (2005) showed that when SARS-CoV ORF 
gene was introduced into an attenuated murine coronavirus, the recombinant virus 
grew faster in cell culture and also exhibited enhanced lethality of infection in mice. 
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Fig. 6. Indirect immunofluorescence used to study cellular localization of nsp8 and ORF6 in SARS-CoV infected Vero 
E6 cells. (Upper panel) Mouse anti-nsp8 (A) and rabbit anti-ORF6 (B) antibodies were used against uninfected cells to 
determine if the antibodies showed any unspecific staining. Nuclei are represented by means of a DAPI stain (C). 
(Middle panel) Vero E6 cells infected with SARS-CoV were examined by indirect immunofluorescence using the same 
antibodies. The expression of nsp8 is represented by FITC staining (E), while the expression of ORF6 is represented by 
Rhodamine staining (F). Nuclei are represented by means of a DAPI stain (G). The merged image showed that the nsp8 
and ORF6 proteins colocalize to punctuate structures in the cytoplasm (H). (Lower panel) Irrelevant antibodies (mouse 
anti-GAL4TA (I) and rabbit anti-flag (J)) were used to probe SARS-CoV infected cells at the same final concentrations as 
their counterparts in the middle panel to show the specificity of the antibodies used in detecting the ORF6 and nsp8 
proteins. 
 
 
Fig. 7. Indirect immunofluorescence was used to probe for LAMP-1 (A, E) and ORF6 (B, F) staining in SARS-CoV 
infected cells (upper panel) and uninfected Vero E6 
cells (lower panel). Nuclei are represented by means of a DAPI stain (C, G). The merged image showed that there is 
colocalization between the LAMP-1 protein and 
ORF6 proteins in SARS-CoV infected cells (D, upper panel). 
 
In contrast, Yount and co-workers reported that the SARS-CoV virus with ORF6 
deleted has the same viral replication kinetics as the wild-type virus in cell-culture and 
mice (Yount et al., 2005). Hence, ORF6 is non-essential for viral replication in these 
models although it cannot rule out that ORF6 (and/or the other accessory proteins of 
SARS- CoV) contributes to the virulence and pathogenesis of SARS coronavirus 
infection in its natural host. Further experiments in more robust animal models, like 
non-human primates that demonstrate clinical disease upon SARS-CoV infection, will 
be needed to determine the actual function of ORF6 during SARS infection  in vivo. 
Since our  data shows that  ORF6 interacts with nsp8 which is part of the replicase 
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complex (Prentice et al., 2004a, 2004b), it will be important in future studies to 
determine if the interaction between  ORF6  and nsp8 can modulate the viral synthesis 
process and to determine how ORF6 modulates viral pathogenesis in these animal 
models. 
 
Materials and methods 
Growth media, yeast strains and plasmid constructs 
All strains, plasmids and plasmid constructs used in this study are described in Table 1. 
The full-length nsp8 and ORF6 genes of the SARS coronavirus (Tor2 isolate) were PCR- 
amplified from a genomic construct of clone NC_004718 (Fig. 1), and cloned into the 
pCR-XL-TOPO vector (Invitrogen). The full-length nsp8 and ORF6 genes were 
subjected to DNA sequencing and the inserts were verified against the corresponding 
region of the SARS coronavirus complete genome NC_004718. The nsp8 gene was 
excised from the pCR-XL-TOPO-nsp8 construct using the restriction enzymes NcoI and  
EcoRI, and ligated  into  the yeast  two- hybrid Activation Domain vector, pACT2 to generate 
an N-terminal in-frame fusion with the GAL4 activation domain (AD). The ORF6 gene was 
excised from the pCR-XL- TOPO-ORF6 construct using the restriction enzymes EcoRI and PstI, 
and cloned into the yeast two-hybrid DNA Binding Domain (BD) vector pGBKT7 in fusion 
with the GAL4 DNA-binding domain to express an N-terminal fusion protein. Similarly 
the NcoI and EcoRI sites were used to clone the nsp8 gene into the pRSET vector to give 
the construct pRSET-nsp8. All DNA manipulations were per- formed as described by 
Sambrook et al. (1989). All constructs were verified by restriction digestion and DNA 
sequencing. 
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Yeast two-hybrid techniques 
The GAL4-based two-hybrid system, kindly provided by Dr. Stephen Elledge (Harper et al., 1993), 
containing pGBKT7 (DNA-binding domain vector) and pACT2 (activation domain vector), together 
with the yeast reporter strain S. cerevisiae AH109 (trp1-901 his3 leu2-3, 112 ura3-52 ade2 
gal4 gal80URA3∷GAL-lacZ LYS2∷GAL-HIS3) were employed. 
 
The host strain containing the Nucleocapsid protein (N) of SARS virus fusion constructs pACT2-
N and pAS2-N, shown previously to form a homodimer (Surjit et al., 2004) was used as a positive 
control. The AH109 host contains integrated copies of both HIS3 and lacZ reporter genes under 
the control of GAL4 binding sites. The AH109 yeast strain was transformed with the 
appropriate plasmids, using the lithium acetate procedure and grown on SD plates in the absence of 
Trptophane (Trp) and Leucine (Leu); (SDTrp− and SDLeu−). 
 
Protein interaction was tested on SD plates without Leu, Trp and Histidine (SDLeu− Trp− His−). 
After 3 days at 30 °C, individual colonies were streaked out and tested for liquid and filter-lift β-
galactosidase activity, 5 mM 3-amino-1,2,3-trizole assay (3AT) and the liquid β-galactosidase assay 
(Ober et al., 2002; Peiris et al., 2003; Pewe et al., 2005). The filter β- galactosidase assay, a 
parameter directly reflecting the strength of protein–protein interactions, was performed by streaking 
doubly transformed yeast colonies onto filter paper and allowing them to grow for 2 days 
on selection medium. Yeast was permeabilized by freezing yeast-impregnated filters in liquid 
nitrogen, and thawing at room temperature. This filter was placed over a second filter that was pre-
soaked in Z buffer (pH 7.0) containing 10 mg/ml 5-bromo-4-chloro-3-indolyl-β- D-
galactopyranoside (X-gal) and 0.27% β-mercaptoethanol. Filters were left for 18 h to develop a 
blue color, which indicated a positive protein–protein interaction. The liquid β- galactosidase 
activity was determined using the substrate CPRG as described previously (Tyagi et al., 2001, 
2002). Relative enzymatic activity was determined in five indepen- dent transformants. Data for 
quantitative assays were collected for yeast cell number and are the mean ± S.E.M. of triplicate 
assays. Appropriate positive/negative controls and buffer blanks were used. The yeast Y187 
host strain containing BD-1111 and AD-1112 were used as positive controls for these assays. 
 
In-vitro cell-free coupled transcription/translation binding analysis 
The 35[S]-methionine labeled full-length pRSET-His6-nsp8 protein (198 amino acids nsp8 with N-
terminal His6-tag) and radiolabelled 
35[S]-methionine full-length ORF6 accessory protein (66 
amino acids with an N-terminal myc tag), were expressed in separate reactions using a coupled 
in-vitro transcription–translation system (TNT coupled reticulocyte lysate system; Promega) as 
per manufacturer's instructions. 10 μl of the His6-nsp8 labeled protein lysate was mixed with 10 μl 
of myc-ORF6 protein lysate. This mixture was incubated on ice for 2 h and the primary antibody (either 
anti-His or anti- myc) was added to the mixture. Subsequently the mixture was incubated at 4 °C for 1 
overnight. Sepharose-A beads were added to the mixture and incubated at 4 °C with gentle shaking 
for 1 h. The beads were washed three times with PBS, resuspended in 10 μl of SDS-PAGE 
loading buffer and boiled for 5 min to dissociate the bound proteins and detected by 
autoradiography. Appropriate control reactions were performed to validate the data. 
 
Mammalian cell cultures 
The CV-1 (African Green monkey kidney) cell-line was a kind gift from Baxter Vaccines, 
Orth/Donau, Austria. The Vero E6 cell-line was purchased from the American Type Culture 
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Collection (Manassas, VA, USA). All cells were cultured at 37 °C in 5% CO2 in DMEM containing 
1 g/l glucose, 2 mM L- glutamine, 1.5 g/l sodium bicarbonate, 0.1 mM non-essential amino acids, 0.1 
mg/ml streptomycin and 100 U penicillin, and 10% FBS (HyClone, Utah, USA). 
 
Generation of ORF6 recombinant replicating vaccinia virus 
ORF6 recombinant replicating vaccinia virus was generated using the system developed by Baxter 
Vaccine (Orth/Donau, Austria). The vector, cell-lines and viruses used here were kind gifts from 
Baxter Vaccine. ORF6 was amplified from cDNA prepared from SARS-CoV infected cells as 
previously described (Tan et al., 2004b) and the pair of primers used is ORF6_forward (5′-
GCAAGCTTATGTTTCATCTTGTTGA-3′) and  ORF6_reverse  (5′-CCGGCGGCCGCTTATGGATAATC- 
TAACACC-3′). The amplicon was digested with HindIII and NotI and cloned into the compatible 
sites of the pDD4-mh5 vector to create plasmid pDD4-mh5/ORF6. The pDD4-mh5 vector can be 
used to generate growth-competent recombinants expressing foreign genes in the D4 locus via a rescue 
method as previously described (Holzer and Falkner, 1997). Essentially, the parental virus lacking the 
D4 gene is replication negative in the usual permissive host lines and only the reintegration of D4 into 
the virus genome allows for growth in these lines. This is in contrast to classical drug-based screening 
approaches which have previously been well established in the generation of vaccinia 
recombinants. 
 
CV-1 cells were grown to 70–80% confluence in 60 mm dishes. Confluent monolayers were 
washed once with PBS, followed by a two washes with 1 ml DME containing no FBS or antibiotics. 
The culture medium was removed and overlaid with 0.2 ml defective vaccinia virus (dVVL) 
(∼multiplicity of infection is 1 pfu/cell) diluted in 0.6 ml DMEM for 1 h at 37 °C in CO2, with 
shaking every 15 min. dVVL is derived from the vaccinia virus Lister strain (ATCC VR-862; 
Ober et al., 2002, and was titered in the complementing cell line RK44.20; Holzer and Falkner, 
1997). The supernatant was removed, replaced with 2 ml DMEM containing no FBS or 
antibiotics and cells were transfected with 5 μg pDD4-mh5/ORF6 using lipofecta-mine reagent 
(Invitrogen, Carlsbad, CA, USA), according to the manufacturer's protocol. After 3 days, 
advanced cytopathic effect was evident and the cells were harvested and subjected to Western blot 
analysis (see below) for determining ORF6 expression. Alternatively, the cells and culture 
supernatant were harvested together and then subjected to three rounds of freeze-thawing and 
clarified by centrifugation at 1500 rpm for 5 min. The supernatant, which constitute the P1 viral 
stock, was used to infect fresh CV-1 cells after which the P2 viral stock was harvested in the same 
manner and stored at − 80 °C before use. 
 
The P2 viral stock was titered in CV-1 cells. This approach of dominant host range selection 
provides a stringent and time- saving method for obtaining vaccinia recombinants carrying 
foreign genes and has been described previously (Holzer et al., 1998). The recombinant vaccinia 
virus expressing the SARS- CoV S protein was previously generated using the same 
methods (Lip et al., 2006). 
 
Expression of viral proteins in mammalian cells and co-immuoprecipitation   
experiments 
The nsp8 gene was PCR amplified from the pRSET-nsp8 plasmid with the following pair of 
primers: nsp8_forward (5′-CGGGATCCGGCACCATGGCTATTGCTTCAG-3′) and 
nsp8_reverse (5′-CCGCTCGAGTCACTGTAGTTTAA- CAGCTG-3′). The amplicon was 
digested with BamHI and XhoI and cloned into compatible sites in the mammalian 
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expression pXJ40myc vector which contains a myc-tag at the N-terminus for ease of detection. 
Typically, ∼ 1× 106 cells Vero E6 were plated on 6 cm dish and allowed to attach overnight and then 
infected with ORF6 recombinant vaccinia virus at a multiplicity of infection of 1. Infection 
media was replaced 1 h post-infection and the cells were transfected with 1 ug of pXJ40myc-
nsp8 using lipofectamine reagent as described above. The cells were harvested ∼ 16 h later 
and lysed in IP buffer (50 mM Tris (pH 8.0), 150 mM NaCl, 0.5% NP40, 0.5% deoxycholic 
acid, 0.005% SDS) and used in co-immunopreci- pitation experiments as previously described 
(Tan et al., 2004c). Briefly, the lysate was incubated with an anti-myc polyclonal antibody (A14, 
Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4 °C, followed by adsorption 
onto a 50 μl suspension of protein A-sepharose beads (Roche Molecular Biochemicals). Beads 
were then washed 3 times with cold IP buffer and subjected to Western blot analysis as 
previously described. Primary antibodies used here were anti-myc mono- clonal (9E10, Santa 
Cruz Biotechnology) and rabbit anti-ORF6 (PUP3, Abgent, San Diego, CA, USA). 
 
For co-immunoprecipitation experiments performed with SARS-CoV infected Vero E6 cells, Vero 
E6 cells were plated in 25 cm2 flasks and infected with an isolate of SARS-CoV (strain 
HKU39849) as previously described (Kaye et al., 2006). The cells were harvest at 0 or 24 
h.p.i. and the lysates were then subjected to Western blot analysis and co-immunoprecipitation 
experiments as described above. Anti-nsp8 monoclonal (described below) and rabbit anti-
ORF6 antibodies were used for Western blot while rabbit anti-flag polyclonal (Sigma) or rabbit 
anti-ORF6 antibodies were used for immunoprecipitation. 
 
Immunofluorescence analysis 
Indirect immunofluorescence was performed using SARS- CoV infected Vero E6 cells as 
previously described (Tan et al., 2004c). Briefly, Vero E6 cells were plated onto 4-well chamber 
slides (Lab-Tek) and infected with an isolate of SARS-CoV (strain HKU39849) as previously 
described (Kaye et al., 2006). 
 
42 h post-infection, chamber slides were washed twice in phosphate-buffered saline (PBS); 
cells were then fixed and permeabilized with methanol for 5 min and subsequently subjected 
to gamma-irradiation to neutralize infectivity of the virus. Cells were then refixed with 4% 
paraformaldehyde and permeabilized with 0.2% Triton X100. Blocking was done using PBS 
with 1% bovine serum albumin (Sigma) and each chamber was incubated with relevant and 
irrelevant control antibodies before being washed with PBS+ 1% BSA several times. Chamber 
slides were then incubated using FITC- conjugated goat anti-mouse and rhodamine-
conjugated goat anti-rabbit secondary antibodies (1:200; Santa Cruz) before being washed 
again and mounted using glass coverslips and a mixture of Fluorsave mounting medium 
(Calbiochem) and Vectashield mounting medium with DAPI (Vector Labora- tories). Imaging 
was done with an Olympus Fluoview upright confocal microscope (Olympus). 
 
Antibodies for detecting endogenous AP-1 and the FLAG epitope were purchased from Sigma 
and antibodies against LAMP-1 and LAMP-2 were purchased from Abcam plc. The anti-
GAL4TA antibody was purchased from Santa Cruz. Monoclonal antibody against the nsp8 
protein was prepared as follows: bacterially expressed glutathione S-transferase (GST)-nsp8 
fusion protein was used to immunize BALB/c mice as previously described (Fielding et 
al., 2004). The spleen was excised from a mouse that showed strong antibody response and 
hybridoma fusion was performed to generate hybridomas producing monoclonal anti-nsp8 
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antibodies as previously described (Lip et al., 2006). All procedures on the use of laboratory 
animals were performed by trained personnel in accordance with the regulations and 
guidelines of the National Advisory Committee for Laboratory Animal Research 
(NACLAR), Singapore. The culture supernatants from several of these hybridoma clones 
were pooled and purified using a HiTrap protein G HP column (Amersham) and verified by 
immunofluoresence assay to be specific to the nsp8 protein. 
 
The mouse monoclonal primary antibodies (mouse anti-nsp8 and anti-GAL4TA) were used at 
concentrations of 0.2 mg/ml and the rabbit polyclonal antibodies (anti-ORF6 and anti-flag) 
were used at concentrations of 0.0025 mg/ml. Identical dilutions of secondary antibodies 
were used for all samples. 
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